Scientific Opinion on the substantiation of health claims related to “wheat dextrin” and maintenance of normal blood pressure (ID 844, 1682), maintenance of normal (fasting) blood concentrations of triglycerides (ID 844, 1682), maintenance of normal blood cholesterol concentrations (ID 844, 1682), reduction of post-prandial glycaemic responses (ID 845, 3096), increase in magnesium and/or calcium retention (ID 846, 3097), short chain fatty acid (SCFA) production in the bowel (ID 1681), decreasing potentially pathogenic gastro-intestinal microorganisms (ID 843, 1681) and maintenance of normal bowel function (ID 843, 1680) pursuant to Article 13(1) of Regulation (EC) No 1924/2006: EFSA-Q-2008-1630 , EFSA-Q-2008-1631 , EFSA-Q-2008-1632 , EFSA-Q-2008-1633 , EFSA-Q-2008-2416 , EFSA-Q-2008-2417 , EFSA-Q-2008-2418 , EFSA-Q-2008-3828 , EFSA-Q-2008-3829

Inge Tetens

Scientific Opinion on the substantiation of health claims related to “wheat dextrin” and maintenance of normal blood pressure (ID 844, 1682), maintenance of normal (fasting) blood concentrations of triglycerides (ID 844, 1682), maintenance of normal blood cholesterol concentrations (ID 844, 1682), reduction of post-prandial glycaemic responses (ID 845, 3096), increase in magnesium and/or calcium retention (ID 846, 3097), short chain fatty acid (SCFA) production in the bowel (ID 1681), decreasing potentially pathogenic gastro-intestinal microorganisms (ID 843, 1681) and maintenance of normal bowel function (ID 843, 1680) pursuant to Article 13(1) of Regulation (EC) No 1924/2006: EFSA-Q-2008-1630 , EFSA-Q-2008-1631 , EFSA-Q-2008-1632 , EFSA-Q-2008-1633 , EFSA-Q-2008-2416 , EFSA-Q-2008-2417 , EFSA-Q-2008-2418 , EFSA-Q-2008-3828 , EFSA-Q-2008-3829

Inge Tetens

National Food Institute

Research output: Book/Report › Report › Research › peer-review

Original language	English

Publisher	European Food Safety Authority
Publication status	Published - 2010

Keywords

short chain fatty acids
calcium
magnesium
Wheat dextrin
blood pressure
retention
health claims
bowel function
gastro-intestinal microorganisms
post-prandial glycaemic responses
cholesterol
triglycerides

OpenUrl availability

Full text

Cite this

Tetens, I. (2010). Scientific Opinion on the substantiation of health claims related to “wheat dextrin” and maintenance of normal blood pressure (ID 844, 1682), maintenance of normal (fasting) blood concentrations of triglycerides (ID 844, 1682), maintenance of normal blood cholesterol concentrations (ID 844, 1682), reduction of post-prandial glycaemic responses (ID 845, 3096), increase in magnesium and/or calcium retention (ID 846, 3097), short chain fatty acid (SCFA) production in the bowel (ID 1681), decreasing potentially pathogenic gastro-intestinal microorganisms (ID 843, 1681) and maintenance of normal bowel function (ID 843, 1680) pursuant to Article 13(1) of Regulation (EC) No 1924/2006: EFSA-Q-2008-1630 , EFSA-Q-2008-1631 , EFSA-Q-2008-1632 , EFSA-Q-2008-1633 , EFSA-Q-2008-2416 , EFSA-Q-2008-2417 , EFSA-Q-2008-2418 , EFSA-Q-2008-3828 , EFSA-Q-2008-3829. European Food Safety Authority.

Tetens, Inge. / Scientific Opinion on the substantiation of health claims related to “wheat dextrin” and maintenance of normal blood pressure (ID 844, 1682), maintenance of normal (fasting) blood concentrations of triglycerides (ID 844, 1682), maintenance of normal blood cholesterol concentrations (ID 844, 1682), reduction of post-prandial glycaemic responses (ID 845, 3096), increase in magnesium and/or calcium retention (ID 846, 3097), short chain fatty acid (SCFA) production in the bowel (ID 1681), decreasing potentially pathogenic gastro-intestinal microorganisms (ID 843, 1681) and maintenance of normal bowel function (ID 843, 1680) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 : EFSA-Q-2008-1630 , EFSA-Q-2008-1631 , EFSA-Q-2008-1632 , EFSA-Q-2008-1633 , EFSA-Q-2008-2416 , EFSA-Q-2008-2417 , EFSA-Q-2008-2418 , EFSA-Q-2008-3828 , EFSA-Q-2008-3829. European Food Safety Authority, 2010.

@book{f1f7bbb52d8345179e6977cdabc58ea2,

title = "Scientific Opinion on the substantiation of health claims related to “wheat dextrin” and maintenance of normal blood pressure (ID 844, 1682), maintenance of normal (fasting) blood concentrations of triglycerides (ID 844, 1682), maintenance of normal blood cholesterol concentrations (ID 844, 1682), reduction of post-prandial glycaemic responses (ID 845, 3096), increase in magnesium and/or calcium retention (ID 846, 3097), short chain fatty acid (SCFA) production in the bowel (ID 1681), decreasing potentially pathogenic gastro-intestinal microorganisms (ID 843, 1681) and maintenance of normal bowel function (ID 843, 1680) pursuant to Article 13(1) of Regulation (EC) No 1924/2006: EFSA-Q-2008-1630 , EFSA-Q-2008-1631 , EFSA-Q-2008-1632 , EFSA-Q-2008-1633 , EFSA-Q-2008-2416 , EFSA-Q-2008-2417 , EFSA-Q-2008-2418 , EFSA-Q-2008-3828 , EFSA-Q-2008-3829",

keywords = "short chain fatty acids, calcium, magnesium, Wheat dextrin, blood pressure, retention, health claims, bowel function, gastro-intestinal microorganisms, post-prandial glycaemic responses, cholesterol, triglycerides",

author = "Inge Tetens",

year = "2010",

language = "English",

publisher = "European Food Safety Authority",

}

Tetens, I 2010, Scientific Opinion on the substantiation of health claims related to “wheat dextrin” and maintenance of normal blood pressure (ID 844, 1682), maintenance of normal (fasting) blood concentrations of triglycerides (ID 844, 1682), maintenance of normal blood cholesterol concentrations (ID 844, 1682), reduction of post-prandial glycaemic responses (ID 845, 3096), increase in magnesium and/or calcium retention (ID 846, 3097), short chain fatty acid (SCFA) production in the bowel (ID 1681), decreasing potentially pathogenic gastro-intestinal microorganisms (ID 843, 1681) and maintenance of normal bowel function (ID 843, 1680) pursuant to Article 13(1) of Regulation (EC) No 1924/2006: EFSA-Q-2008-1630 , EFSA-Q-2008-1631 , EFSA-Q-2008-1632 , EFSA-Q-2008-1633 , EFSA-Q-2008-2416 , EFSA-Q-2008-2417 , EFSA-Q-2008-2418 , EFSA-Q-2008-3828 , EFSA-Q-2008-3829. European Food Safety Authority.

Scientific Opinion on the substantiation of health claims related to “wheat dextrin” and maintenance of normal blood pressure (ID 844, 1682), maintenance of normal (fasting) blood concentrations of triglycerides (ID 844, 1682), maintenance of normal blood cholesterol concentrations (ID 844, 1682), reduction of post-prandial glycaemic responses (ID 845, 3096), increase in magnesium and/or calcium retention (ID 846, 3097), short chain fatty acid (SCFA) production in the bowel (ID 1681), decreasing potentially pathogenic gastro-intestinal microorganisms (ID 843, 1681) and maintenance of normal bowel function (ID 843, 1680) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 : EFSA-Q-2008-1630 , EFSA-Q-2008-1631 , EFSA-Q-2008-1632 , EFSA-Q-2008-1633 , EFSA-Q-2008-2416 , EFSA-Q-2008-2417 , EFSA-Q-2008-2418 , EFSA-Q-2008-3828 , EFSA-Q-2008-3829. / Tetens, Inge.

European Food Safety Authority, 2010.

Research output: Book/Report › Report › Research › peer-review

TY - RPRT

T1 - Scientific Opinion on the substantiation of health claims related to “wheat dextrin” and maintenance of normal blood pressure (ID 844, 1682), maintenance of normal (fasting) blood concentrations of triglycerides (ID 844, 1682), maintenance of normal blood cholesterol concentrations (ID 844, 1682), reduction of post-prandial glycaemic responses (ID 845, 3096), increase in magnesium and/or calcium retention (ID 846, 3097), short chain fatty acid (SCFA) production in the bowel (ID 1681), decreasing potentially pathogenic gastro-intestinal microorganisms (ID 843, 1681) and maintenance of normal bowel function (ID 843, 1680) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

T2 - EFSA-Q-2008-1630 , EFSA-Q-2008-1631 , EFSA-Q-2008-1632 , EFSA-Q-2008-1633 , EFSA-Q-2008-2416 , EFSA-Q-2008-2417 , EFSA-Q-2008-2418 , EFSA-Q-2008-3828 , EFSA-Q-2008-3829

AU - Tetens, Inge

PY - 2010

Y1 - 2010

KW - short chain fatty acids

KW - calcium

KW - magnesium

KW - Wheat dextrin

KW - blood pressure

KW - retention

KW - health claims

KW - bowel function

KW - gastro-intestinal microorganisms

KW - post-prandial glycaemic responses

KW - cholesterol

KW - triglycerides

M3 - Report

BT - Scientific Opinion on the substantiation of health claims related to “wheat dextrin” and maintenance of normal blood pressure (ID 844, 1682), maintenance of normal (fasting) blood concentrations of triglycerides (ID 844, 1682), maintenance of normal blood cholesterol concentrations (ID 844, 1682), reduction of post-prandial glycaemic responses (ID 845, 3096), increase in magnesium and/or calcium retention (ID 846, 3097), short chain fatty acid (SCFA) production in the bowel (ID 1681), decreasing potentially pathogenic gastro-intestinal microorganisms (ID 843, 1681) and maintenance of normal bowel function (ID 843, 1680) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

PB - European Food Safety Authority

ER -

Tetens I. Scientific Opinion on the substantiation of health claims related to “wheat dextrin” and maintenance of normal blood pressure (ID 844, 1682), maintenance of normal (fasting) blood concentrations of triglycerides (ID 844, 1682), maintenance of normal blood cholesterol concentrations (ID 844, 1682), reduction of post-prandial glycaemic responses (ID 845, 3096), increase in magnesium and/or calcium retention (ID 846, 3097), short chain fatty acid (SCFA) production in the bowel (ID 1681), decreasing potentially pathogenic gastro-intestinal microorganisms (ID 843, 1681) and maintenance of normal bowel function (ID 843, 1680) pursuant to Article 13(1) of Regulation (EC) No 1924/2006: EFSA-Q-2008-1630 , EFSA-Q-2008-1631 , EFSA-Q-2008-1632 , EFSA-Q-2008-1633 , EFSA-Q-2008-2416 , EFSA-Q-2008-2417 , EFSA-Q-2008-2418 , EFSA-Q-2008-3828 , EFSA-Q-2008-3829. European Food Safety Authority, 2010.